View Post

Rare Patient Voice: Study Opportunity for Multiple Cancer Types

In Paid Opportunities For The Cancer Community by Barbara Jacoby

Study Details: Cancer patients with any of the following cancer types: Breast Prostate Skin (Melanoma and Basal Cell) Bladder Kidney Lung 60 min Online Bulletin Board US patients only Compensation $100 Please sign up at the link below for more information or to see if you qualify. http://letlife.in/rare-patient-voice Why Sign up with Rare Patient Voice? Who knows better than you …

View Post

Scientists identify obscure protein responsible for advanced breast cancer

In In The News by Barbara Jacoby

By: University of South Australia From: medicalxpress.com South Australian scientists have made a critical breakthrough, discovering how an obscure protein causes breast cancer to develop and grow more quickly. High levels of a protein called Creld2 have been linked to the most aggressive types of breast cancer with lower survival rates, according to Associate Professor Michael Samuel, a senior UniSA …

View Post

Clinical Trial Saves Life of Stage 4 Kidney Cancer Patient

In Clinical Studies News by Barbara Jacoby

By: Bianca Castro From: nbcdfw.com When a well-known journalist in Dallas learned he had stage 4 kidney cancer, he was told he had three, possibly four, years to live. One year, later, the tumor threatening his life is gone and it’s thanks to a clinical trial at UT Southwestern. Robert Wilonsky will tell you there’s nothing special about him. He’ll …

View Post

Spanish Language Version of Pioneering Patient History Study Launched

In In The News by Barbara Jacoby

Source: VHL Alliance From: prnewswire.com Information brings researchers one step closer to Curing Cancer Through VHL The VHL Alliance’s launch of a Spanish language version of its breakthrough patient history study brings the VHL community and researchers one step further to finding a Cure for Cancer through VHL. Developed in collaboration with NORD (the National Organization of Rare Disorders), with …

View Post

Cancer Can Start To Develop Fifty Years Before Diagnosis

In In The News by Barbara Jacoby

By: Victoria Forster From: forbes.com Scientists studying kidney cancer have found that the first DNA damage eventually leading to cancer can occur as early as childhood, in some cases fifty years before diagnosis. In a trio of studies simultaneously published on Thursday in the journal Cell, researchers have provided vital new information as to how kidney cancer begins, evolves and progresses, which they hope will lead …

View Post

Doctors Excited By Results Of New Immunotherapy Cancer Treatment

In In The News by Barbara Jacoby

By: Dr. Maria Simbra From: pittsburgh.cbslocal.com No chemotherapy, No radiation. There’s a new way to treat cancer that doesn’t involve either. It’s working for patients and even doctors are excited about it. Joe Milcarek had no symptoms of lung cancer. Doctors discovered it on scans he had as part of participation in a lung study. “They found a tumor about …

View Post

Cancer cells’ stealth mechanism uncovered

In In The News by Barbara Jacoby

By: Michael Franco From: newsatlas.com When a malignant tumor invades the body, immune cells rush to the site to begin to fight it. When that same tumor spreads throughout the body, however, the cancer cells become invisible to our immune systems and can metastasize unencumbered by our natural defenses. Researchers out of the University of British Columbia (UBC) are on …

View Post

Kidney cancer treatment: Potential for new classes of HIF inhibitors

In In The News by Barbara Jacoby

Source: CUNY Advanced Science Research Center From: sciencedaily.com New insights into the potential for new classes of HIF inhibitors to restore control of the hypoxia response — representing the potential foundation of a new cancer-fighting strategy — are the focus of recently published articles in Nature and Structure featuring work by Kevin Gardner of the City University of New York’s …

View Post

First 3-D map of cell-building protein linked to cancer

In In The News by Barbara Jacoby

Source: Walter and Eliza Hall Institute From: sciencedaily.com Walter and Eliza Hall Institute researchers have revealed for the first time the three-dimensional molecular ‘map’ of a protein that has been pinpointed as a driver of many types of cancers. The unprecedented view of the protein doublecortin kinase like domain 1 (DCLK1) could provide clues to how it contributes to cancer …

View Post

Nearly 1 in 12 patients with a common cancer develop a second, unrelated malignancy

In In The News by Barbara Jacoby

By: Kim Irwin From: ucla.edu Reported by: Redington Life Sciences News UCLA researchers have identified the incidence and long-term outcomes of patients who develop second, unrelated cancers, resulting in a data set that they say sheds new light on the way cancer survivors may need to be monitored post-disease. The researchers identified more than 2.1 million patients from the Surveillance, …